Article citationsMore>>

G. Perilongo, R. Maibach, E. Shafford, L. Brugieres, P. Brock, B. Morland, et al., “Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma,” New England Journal of Medicine, Vol. 22, No. 361, 2009, pp. 1662-1670. doi:10.1056/NEJMoa0810613

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top